The impact of COVID-19 on people with diabetes in Brazil

Barone, Mark Thomaz Ugliara; Harnik, Simone Bega; Luca, Patrícia Vieira de; Lima, Bruna; Wieselberg, Ronaldo José Pineda; Ngongo, Belinda; Pedrosa, Hermelinda Cordeiro; Pimazoni-Netto, Augusto; Franco, Denise Reis; Marinho, Fátima; Malta, Déborah Carvalho; Giampaoli, Viviana

doi:10.1016/j.diabres.2020.108304

Cited by 69 publications

(111 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The study also reported an increase in food intake (29.71%) among diabetics. In line with recommendations suggested by Barone et al., internet and television broadcasting can be used as an effective medium to create awareness among people of habits and behaviors, such as regular physical activity [ 16 ]. However, the use of television by participants was not investigated in the current study.…”

Section: Discussionmentioning

confidence: 99%

“…The lower-income countries and countries moving in to transition towards the community transmission are being majorly affected [ 15 ]. A recent study in the Brazilian population revealed the impact of COVID-19 on diabetics [ 16 ]. India harbors 77 million diabetes patients, which makes it the second most affected nation in the world, after China.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Khader

Jabeen

Namoju

2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

Background and aims: Uncontrolled diabetes has been associated with poorer clinical outcomes in COVID-19. We aimed to evaluate and assess the impact of COVID-19 pandemic on management of diabetes and challenges faced by people with diabetes in India during and after the lockdown phase. Methods: A cross-sectional study based on an online questionnaire survey was designed. The questions collected socio-demographic details, medical and social history, and impact of the pandemic on medical and social life from 1582 participants. Linear regression was employed to evaluate association of different parameters with the change in glycemic levels. Results: The frequency of clinical visits during the COVID-19 pandemic were reduced in 87.28% of participants. 92.45% of participants were able to monitor their blood glucose levels (BGLs) in which 78.42% (49.35%, 20.91%, and 8.16%) participants experienced an increase in BGL (mild, moderate, and severe respectively). Only 47.41% of participants possessed the digital glucometer at home. 69.07% of participants reported a decrease in physical activity while 46.88% reported an increase in food intake. 80.06% of participants were able to buy all medicines and 29.80% were gone for virtual consultations while 87.81% reported that they didn’t have access to healthcare services. Overall, 89.47% participants experienced disruption in therapy. A highly significant correlation (r = 0.89, p = 0.0145) was found between increasing age and reporting of higher BGLs. Conclusion: This study provides a firsthand evidence of major disruption in diabetes care activities during and after the lockdown phase in India and increased risk of poorer clinical outcomes, if infected by SARS-CoV-2.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Khader

Jabeen

Namoju

2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

show abstract

“…A possible explanation for this result is the socio-economic profile of these specific respondents, only 16.22% have private insurance. Therefore, as hypothesized by Barone et al (2020) [ 18 ], this may be explained by an unequal impact of the pandemic. Goiás is an opposite example, where almost half of the respondents (49.12%) have private insurance, and it counts with the highest percentage of individuals receiving medicines for three months - but still with much less than half (35.48%) - and one of the lowest percentage of blood glucose deterioration - though still very high (47.17%).…”

Section: Discussionmentioning

confidence: 87%

“…The online survey was only answered by individuals with diabetes of legal adulthood age (eighteen or older) with the form being transmitted once the respondent consented with the terms for participation. An initial general analysis of the responses was made covering all the 1701 answers [ 18 ], but did not include analysis by state. Thereafter, we decided that additional analyses by state would help to understand if measures to protect individuals with diabetes were more effective in certain states than in others.…”

Section: Methodsmentioning

confidence: 99%

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Barone

Harnik

Chaluppe³

et al. 2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

Self Cite

View full text Add to dashboard Cite

Background and aims COVID-19 severity and mortality are elevated in individuals with diabetes. During the pandemic, interventions recommended globally for people with diabetes were to keep blood glucose on target whilst staying at home to curb the spread of the virus. In Brazil, similar measures were proposed. The aim of our observational study was to assess whether these measures achieved their objectives. Methods : An anonymous and untraceable survey was shared from April 22nd to May 4th. States with more than 30 respondents were included in the analysis and Fisher's exact test was performed to identify associations, with p < 0.05 considered significant. Results: Type 1 diabetes and female participants were prevalent, 60.76% and 76.12% respectively. 10 out of 26 states were included, in addition to the federal district (1562 responses). Only in three states (Bahia, Goiás and Pernambuco) less than 50% of the respondents experienced higher glycemia or higher variability during the pandemic. Goiás state, where almost half of the respondents (49.12%) have private insurance, presented the highest percentage of individuals receiving medicines for three months (35.48%) and one of the lowest percentages of blood glucose deterioration (47.17%). In the large states of Minas Gerais, Rio de Janeiro and São Paulo, consultations and/or lab exams were postponed by 37.14%, 34.33% and 40.88%, respectively. Conclusions: The decentralized measures implemented by states in Brazil left most people with diabetes unprotected. Many were forced to venture outside to collect or to purchase their monthly medical supplies and reported increased glycemic levels and/or variability.

show abstract

“…O Brasil está entre os 5 principais países em relação à prevalência de DM, com um total de 16,8 milhões de pessoas portadores ou 11,4% da população entre 20 e 79 anos. Além disso, observa-se mais de 135.000 mortes causadas por essa condição e suas complicações anualmente (BARONE et al, 2020).…”

unclassified

Influência do DM2 e do controle glicêmico no prognóstico de pacientes infectados por COVID-19

Aquino

Silva

Oliveira

et al. 2020

BJHR

View full text Add to dashboard Cite

RESUMO Objetivo: Verificar, por meio de uma revisão narrativa de literatura, a influência do DM2 no prognóstico da infecção por COVID-19, assim como o impacto do controle glicêmico nos desfechos apresentados por esses pacientes. Revisão bibliográfica: A DM2 relaciona-se com a infecção e a gravidade da SARS-CoV-2. Os sintomas apresentados pelos pacientes diabéticos infectados por SARS-CoV-2 foram muito amplo, entretanto, percebeu-se maior comorbidade nas análises laboratoriais e de imagem, além de maior mortalidade entre os pacientes diabéticos infectados pelos novo coronavírus. A literatura divergiu ao comparar o quadro clínico do pacientes diabéticos e não diabéticos infectados por COVID-19, mas convergiu ao relatar aumento da morbimortalidade. Considerações finais: A adaptação metabólica promovida pelo indivíduo diabético se mostra prejudicial no contexto do COVID-19, predispondo o paciente à infecção e ao surgimento de outras complicações, além de determinar um pior controle glicêmico e prognóstico. Tais achados destacam a necessidade de uma abordagem multidisciplinar para o gerenciamento dessa população de pacientes visando à prevenção de complicações e de formas graves da infecção.

show abstract

The impact of COVID-19 on people with diabetes in Brazil

Cited by 69 publications

References 47 publications

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Influência do DM2 e do controle glicêmico no prognóstico de pacientes infectados por COVID-19

Contact Info

Product

Resources

About